These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6478305)

  • 1. Ocular adverse reactions to drug formulations: core information from the Canadian registry.
    Begg IS
    Can J Ophthalmol; 1984 Aug; 19(5):205-6. PubMed ID: 6478305
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular adverse drug reactions and the National Registry of Drug-Induced Ocular Side Effects.
    Fraunfelder FW
    Insight; 2004; 29(2):7-11. PubMed ID: 15709350
    [No Abstract]   [Full Text] [Related]  

  • 3. The national registry of drug-induced ocular side effects.
    Fraunfelder FT; Meyer SM
    Aust J Ophthalmol; 1984 May; 12(2):129-31. PubMed ID: 6487182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects.
    Fraunfelder FW; Fraunfelder FT
    Ophthalmology; 2004 Jul; 111(7):1275-9. PubMed ID: 15234126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National registry for drug-induced ocular side effects.
    Fraunfelder FT
    JAMA; 1977 Jan; 237(5):446. PubMed ID: 576259
    [No Abstract]   [Full Text] [Related]  

  • 6. [Polymers in ocular drug formulations].
    Torres Suárez AI
    Arch Soc Esp Oftalmol; 2002 Feb; 77(2):59-60. PubMed ID: 11854855
    [No Abstract]   [Full Text] [Related]  

  • 7. Registry pools reports on ocular side effects.
    Cole H
    JAMA; 1985 Oct; 254(13):1690. PubMed ID: 4032667
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse drug reactions in Canada. Bisphosphonates and ocular disorders.
    Can Fam Physician; 2004 Mar; 50():422-4. PubMed ID: 15318681
    [No Abstract]   [Full Text] [Related]  

  • 9. Interim report: National Registry of possible Drug-induced Ocular Side Effects.
    Fraunfelder FT
    Ophthalmology; 1980 Feb; 87(2):87-90. PubMed ID: 7383547
    [No Abstract]   [Full Text] [Related]  

  • 10. [Classification and profile of adverse drug effects].
    Cordonnier M
    Bull Soc Belge Ophtalmol; 2007; (304):15-6. PubMed ID: 17718223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will you help develop a registry of drug-induced ocular side effects?
    Fraunfelder FT; Huffman DC
    Pharm Times; 1978 Jun; 44(6):50-1. PubMed ID: 10307776
    [No Abstract]   [Full Text] [Related]  

  • 12. National Registry of Drug-Induced Ocular Side Effects.
    Fraunfelder FT
    Am J Ophthalmol; 1990 Oct; 110(4):426-7. PubMed ID: 2220981
    [No Abstract]   [Full Text] [Related]  

  • 13. Interim report: National Registry of Possible Drug-Induced Ocular Side Effects.
    Fraunfelder FT
    Ophthalmology; 1979 Jan; 86(1):126-30. PubMed ID: 530559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drugs and the eye. Ocular reactions to systemic therapy with beta blockers (I)].
    Cherecheş S
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1987; 31(1):47-52. PubMed ID: 2885901
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug reactions in ophthalmology.
    Chatterjee PR; Chattopadhyay DN; Baidya BK; Guha G
    J Indian Med Assoc; 1985 Feb; 83(2):55-8. PubMed ID: 4056419
    [No Abstract]   [Full Text] [Related]  

  • 16. Ocular side effects from herbal medicines and nutritional supplements.
    Fraunfelder FW
    Am J Ophthalmol; 2004 Oct; 138(4):639-47. PubMed ID: 15488795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse drug reactions in ophthalmology - update 2011/12].
    Schlote T; Kellner U
    Klin Monbl Augenheilkd; 2012 Mar; 229(3):273-90; quiz 291-2. PubMed ID: 22241578
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings of the First Congress of the International Society of Ocular Toxicology. Toronto, Canada, June 1988.
    Lens Eye Toxic Res; 1989; 6(1-2):1-393. PubMed ID: 2577306
    [No Abstract]   [Full Text] [Related]  

  • 19. Industrial perspective in ocular drug delivery.
    Ali Y; Lehmussaari K
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1258-68. PubMed ID: 17079049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of a common ocular complaint.
    Straughan JL
    S Afr Med J; 1979 Mar; 55(9):320. PubMed ID: 441892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.